For example, median survival among patients with IDH-mutant grade IV astrocytomas can reach approximately 31 months, compared to only 15 months in those with IDH wild-type tumors [31,32,33]. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).